Oracle is moving to stop maintaining the macOS/x64 port of the Java Development Kit (JDK) from version 27, which is expected in September. JEP (JDK Enhancement Proposal) 8386091 states that "Oracle ...

Oracle reduced its workforce by 13% over the past 12 months and cited AI deployment in an annual filing on Monday. The company currently employs 141,000 full-time workers, down from 162,000 the ...

Hims & Hers Health (HIMS) on Thursday announced the launch of generic versions of Novo Nordisk’s (NVO) blockbuster GLP-1 therapy semaglutide through its telehealth platform in Canada. The ...

Execution infrastructure converts early commercial and supply signals into owned, cross-functional workflows with decision logic and closure tracking, preventing insights from stalling in dashboards.

Dr. Reddy's Laboratories (NVO) will launch its off-patent version of Novo Nordisk’s (NVO) blockbuster GLP-1 therapy Ozempic in Canada within the “next few days,” becoming the first to sell a generic ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The day has ...

Executives insist Novartis will return to growth in the second half, but for Q1 2026, generic erosion drove a 5% drop in revenue, including a 46% nosedive for blockbuster heart failure drug Entresto.

This is read by an automated voice. Please report any issues or inconsistencies here. See more from the L.A. Times in Google Search. Set us as preferred Software giant Oracle on Tuesday started laying ...

Oracle has cut an unspecified number of jobs as the software giant looks to reduce costs and continue growing its artificial intelligence business, according to former employees and multiple reports.

The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions. By Rebecca ...

At the JavaOne conference today, Oracle made a series of announcements related to a new Java Verified Portfolio (JVP) and new JDK Enhancement Proposals (JEPs). The JVP is designed to give developers a ...